Special situation · 154 dossiers

AI-server and enterprise-networking pivot is real at the theme level, but HPE's own chart broke: the record +25% Q2 FY26 blowoff (2026-06-02, ATH $64.25) fully round-tripped, the ~$48 pre-print shelf failed (last observed close $43.71 on…

NetApp's first genuine AI re-rating (2026-05-28 Q4 print) is now digesting the ~35% gap to $192.83 has round-tripped to the ~$150 breakout-retest zone by 2026-06-26. FY27 revenue guided only +8%, no company binary until ~late-August Q1.…

Stalled single-cell franchise re-rating on the spatial/multiomics pivot: Atera (ships H2 2026), Proteintech protein capability, and a Cleveland Clinic clinical tie-up extend the story while a July cluster of analyst target raises ($40–$50)…

Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) late-stage distribution behaviour. The 2026-07-29 Q2 print…

Operating story and equity have decoupled: >1 GW contracted and ~$31B backlog, yet the stock halved from $49.65 (2026-05-28) to $25.79 (2026-07-17) on a ~$2.7B debt load, widening GAAP losses and CoreWeave concentration. Price now sits on…

Neocloud re-rate has fully round-tripped: $33.62 close 7/17, -42% in 30 days, late-May Microsoft breakout base surrendered. Contracts intact ($9.7B MSFT, prepaid tranches) but Q3 AI revenue was only $17.3M vs a $3.4B ARR ambition, and…

Legacy crypto-financials name re-rating to AI-data-center landlord: Phase I ~200MW at the Helios campus was delivered to CoreWeave on 2026-07-06, turning the ~$4.5B/15-yr lease from promise into live contracted revenue while shares still…

Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)…

Foundry-revival re-rating has unwound hard: INTC -31% in July vs TSM -15%, the ~$92 announcement shelf is gone, and SOXX just posted its worst month ever versus software. The 2026-07-23 Q2 print (18A yield, foundry loss, client CPU share)…

The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math…

BTC-to-AI-landlord re-rating is structurally intact AMD $311M/50MW Rockdale lease, $33.2M Q1 data-center revenue, Citi reiterated Buy/PT $28 on 2026-07-08 but the miner complex rolled over on a Q2 crypto rout and "fresh AI-pivot headwinds"…

Conway extract/RTD platform inflecting capex to cash: Q1 (5/07) beat revenue with record adjusted EBITDA, FCF-positive-H2 guide reaffirmed, and a 6/30 debt-maturity extension cleared the near-term refi wall. Stock re-rated ~the published…

Life-settlements franchise attached itself to the RWA-tokenization narrative on 2026-07-07 (100+ policies on-chain, targeting the $224B secondary market by year-end); Q1 beat and raised FY adj-EPS guide to $1.00–1.05. But price rejected…

ADVA-merger margin turnaround confirmed (Q1 5/4: rev $286M +15.5%, non-GAAP GM 43%), but the ~$7→$20 run has rolled over down ~20% on the month to ~$13, losing the $14–15 shelf while the AI-optical cohort (CIEN/LITE/COHR +100% YTD) rips…

Frac-sand legacy name pivoting to behind-the-meter gas power for AI data centers, but the post-Caterpillar re-rating has round-tripped: shares lost the ~$15 breakout base to $14.39 (7/10), no new PPA since 4/1, and a Russell growth-index…

Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that…

Legacy ethanol/specialty-alcohol pivot re-rated ~6x off $0.92; Russell 2000/3000 add (eff. 2026-06-26) drove a new 52-week high of $6.11 in early July, but that passive-flow catalyst is spent and price has faded to ~$5.63. Maturing…

Healthcare-staffing cyclical recovery, real but MATURING: shares printed fresh 52-wk highs ~$32.5 (+105% YTD off $15.77) yet sit ~30% above the ~$25.29 avg PT with a soft Q2 guide and no upgrade cluster. Extended entry into overhead target…

Value-unlock special situation, not momentum: ~$10.90/share net cash, Politan (~10%) on the board, and portfolio simplification now executing B Medical Systems divestiture closed Jul 8. But the +60% bounce off $15.93 has stalled in the…

Lemonis "Everything Home" roll-up accelerating on deal cadence (TwoPonds, Affirm BNPL, Tokens.com, all ~2026-07-01), but the BBBY tape stays pinned near its 52-week low (~$5.83 vs $4.26) a story-stock value trap until price reclaims…

Rotation-passenger thesis is dead: BBWI broke its multi-year base and sits ~36% off its high near 52-week lows while the tape makes records. Only live leg is a nascent self-help turnaround Ulta wholesale launch 2026-07-12, Consumer First…

Tape flipped since early July: BBY broke to a fresh 52-week high $87.35 (~$85.41 on 2026-07-17, +27.6% YTD) on RGB-LED TV exclusivity plus an AI-PC/MacBook refresh cycle. But price sits ~8% above the $79.15 consensus target while Loop…

The premium-to-book re-rating has unwound: BH ~$384 (Jul 17) sits back under the ~$401/Class B book line while CBRL rallied to $53.61 the holdco is falling as its main asset rises, re-widening the discount. A $500M ATM with ~$485M undrawn…

Casual-dining turnaround already re-rated: seven straight quarters of traffic growth under CEO Tick, but Q1 comps decelerated to +2.4%, FY guide is just +1–3%, price sits ~30% above every analyst PT, and insiders sold the June high. Mature…

The +80% Q1 turnaround re-rate has fully round-tripped from the $6.57 high: BLDP lost the 20-EMA near $5.00 and the $4.80 breakout shelf, sits in a catalyst vacuum until the 2026-08-12 Q2 print, and Susquehanna's 2026-07-10 cut to $3.50…

Post-ASMS product-cycle re-rate has matured into a based-out momentum leg: the low-$40s→$64.54 June run held near $55, and the sell-side kept chasing Guggenheim $53→$70 (2026-06-29), Leerink Outperform $70 (2026-07-07), Citi Neutral $60…

Broken wrapper on an accelerating underlying: WhiteFiber (WYFI, ~70% owned) held $38.50 on its 7/9 cross-datacenter networking milestone, but BTBT de-rated to $1.69 toward its $1.25 52-week low blowing the SOTP discount out to ~54% (the…

Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the…

De-levering small-cap orthobiologics turnaround, now maturing: the July-2025 refi killed the 2026 debt wall, margins inflected above 20%, and the stock re-rated ~+117% to within 4% of its 52-week high. The easy money is largely priced; the…

Casual-dining re-rate got a genuine second leg: Citi's 2026-07-10 raise to a street-high $90 (Buy) on a rewards/app traffic-inflection thesis gapped shares 7% to all-time highs (~$86, 52wk high $86.66 on 2026-07-18). For the first time the…

Post-earnings drift has cut the stock ~19% from its pre-print ~$14.51 to $11.81 (2026-07-10), slicing the low-$13s June base as the spent Q1 catalyst left no momentum leg. Cheap on forward numbers (~7.7x, ~$57.8M tariff-refund optionality…

Capital-light auto marketplace compounding per-share via a 29%-of-float buyback and steady ~15% marketplace growth, but the theme is MATURING, growth is decelerating (Q2 guide +11-14% vs Q1 +15%), and the 2026-08-06 print is a binary with…

Q3 FY26 beat + raised FY26 guide ($3.27–3.30B vs $3.25B) confirmed the legacy-diner turnaround, but the catalyst fired five weeks ago, the rotation cooled to maturing, and the next print is ~September. A 2026-07-13 13G/A (D.E. Shaw…

Analyst-confirmed profitability inflection (Q1'26: adj-EBITDA +$4.0M, +$6.2M op cash, +24% product rev) in a 25-year blood-safety grinder but the 2.7x off the lows is largely spent and price is pinned at 52-week highs (~$3.19 vs $3.21).…

Fallen drug-development software name grafting an NVIDIA agentic-AI headline onto a broken tape: May 11 FY26 guidance cut ($0.35–0.41 EPS), CFO exit July 14, and a faded July NVIDIA pop leave price ~$6.90 rolled over below all MAs near…

GOES re-rating has fully round-tripped: ~$9.79 vs the $16.70 52-wk high, -22.3% in a month, price now BELOW four of five freshly cut targets. The $400M DoD award (7/1) was sold; Weirton transformer plant was cancelled in 2025 and POSCO is…

Post-Anywhere synergy inflection has re-accelerated: COMP ripped ~+30% off the June AG-probe low near $9.78 to ~$12.70 on a doubling in Coldwell Banker luxury demand and Barclays' $12→$15 upgrade. Now stretched into a binary ~2026-07-29 Q2…

Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical…

Solar policy-relief rally is dead CSIQ round-tripped $34.59 (May) to $14.75 (Jul 8) as the July 4 ITC deadline passed into a demand-cliff narrative. The US-HJT reshoring/45X pivot is real but a 2027 P&L event; broken below all MAs into a…

Currency/payments spinoff re-rating into an authentication & traceability roll-up (De La Rue + Antares Vision); SAT sales +51% YoY, FY sales guide hiked to 15–17%. A June 27 Russell large-cap ejection forced a washout to ~$47.48; price is…

June's $50M raise at $3.05 (16.4M sh) is already underwater: shares last $2.775 (2026-07-02), below the offering floor, with ~$50M shelf undrawn and soft Q2 guidance (rev $93–95M, adj. EBITDA still negative) into the 2026-08-10 print. A…

Railcar-inspection shell re-rated into an AI data-center/edge-compute + behind-the-meter power operator. July-7 Nistar 2 MW MSA and Russell 2000 inclusion rebuild the story above the $9.50 secondary floor, but structure stays broken below…

Post-Colfax orthopedic pure-play turnaround: LimaCorporate integration plus FCF-conversion recovery (43% in 2024 toward a 70–80% target) is the self-help story, but price has rolled over from $34 toward $27 while three brokers cut targets.…

IQ SST AI-data-center pivot (announced 2026-04-28) that drove a spring squeeze has stalled stock de-rated ~16% in a month to ~$45 (2026-07-09), sell-side uniformly neutral with PTs on top of price (Susquehanna $45, 2026-07-10), and SST…

Smadex AI-DSP re-rate is real ATS net revenue +204% YoY in Q1 2026 but the move has matured into a tight consolidation on ~77% lighter volume with no dated catalyst until the ~early-August Q2 print; the TelevisaUnivision affiliation expiry…

Declining expense-SaaS attempting an agentic-finance re-rate: MCP launch (Jun 8) + Concierge AI agents (Jul 1) are the narrative leg, but the core is still shrinking revenue -6% and paid members -4% YoY in Q1 (May 7). The 2026-08-06 Q2…

Legacy campus-networking name re-rating ~+140% off Feb lows on the Platform ONE / Agent ONE AI-NetOps story plus SaaS ARR +29% YoY; theme still ACCELERATING but spot ($33.71, 07-10) has run through consensus PT $29.06 into the June bull…

Sterling-integration turnaround already re-rated FA tripled off an $8.82 low to ~$22 and now sits above every sell-side target into an Aug 6 Q2 print, with June hiring softening (57k vs 129k) threatening the volume base. Late-leg, not…

Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays…

Legacy-CCaaS AI pivot staged a sharp V-recovery: +29% off the $19.70 June swing low to $25.42, reclaiming the broken $22 shelf on a 2026-06-23 next-gen Voice AI Agents launch and an AI-first leadership overhaul. Now pressing the $26.26…

AI-manufacturing re-acceleration: the 2026-07-09 Cerebras CS-3 production expansion is the first company-specific bid since the S&P-inclusion +6% pop round-tripped to ~$147, refreshing the data-center power/EMS narrative into the ~07-29 Q1…

CRO margin-turnaround already re-rated FTRE ~4x off its 2025 low; the Q1 beat that drove it is spent and price sits ~9% under the $18.67 52-week high, above most analyst targets. Fresh positive drift (Zacks Strong-Buy 7/7 on +31% estimate…

Legacy consumer-security roll-up repaired from $23.31 (2026-06-25) to ~$26, reclaiming the $24 shelf but not the $27.76 earnings high; fresh AI-trust-layer angle (Norton Genie into Claude, 2026-06-30) is real but unmonetized. The…

Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to…

Plasma/IVIG re-rating has stalled just under YTD highs (~$76) as sell-side finishes flipping from cuts to raises now the base case rather than an edge. Citi's July 8 "downside 90-day catalyst watch" (PT $79, Neutral) frames the Aug 6 Q1…

Q1 FY2027 (2026-07-08) beat the guided-breakeven bar Adj EPS $0.17 vs $(0.01) est, sales $402M vs $375M, sales guide nudged up and analysts lifted PTs to $25–28. The turnaround binary resolved favorably, but the stock now sits at fair…

BTC-miner→AI-compute re-rating has its first blue-chip proof BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR but the stock stalled ~$3.79 — below its early-June highs as BTC bled ~45-50% off…

Transformational Steelcase merger (closed 2025-12-10) made HNI the #1 North American office-furniture maker at ~$5.8B revenue, but the tape is broken near $40 versus ~$70 analyst targets a show-me integration grind, not an accelerating…

Freight-cycle recovery has a stronger structural leg than the rate data alone implied regulatory driver purge (~194k CDLs, ELP enforcement) plus spot above contract for the first time since 2021. But HTLD is unprofitable, all six covering…

Med-device turnaround re-rating is now fully banked into Hold-grade targets: BMO initiated Market Perform $19 (Jul 9) and Citi raised to Neutral $19 (Jul 8), both landing on the tape (~$18.76). The distressed-to-fair leg is done; only…

Section 232 aluminum supply-shock (50% duty through 2027) plus a Q1 earnings inflection already repriced KALU ~+175% YoY to a $195 high; the move is MATURING toward SATURATED with price at/above every published target. The estimated…

Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero…

Cyclical staffing recovery is fully printed Q1 returned to YoY growth, Q2 guided +~4% but price ran ~24% in three weeks to a fresh all-time high near $58.6, ~38% above the $42.33 consensus PT, into the confirmed 2026-07-27 Q2 print. A…

Pension-reversion fat pitch fired and is spent; the re-rate has fully unwound from the $14.87 May high to ~$7.78, losing the $9 June shelf and printing a $4.94 52-week low. A July 1 resale shelf of up to ~39.46M shares and a June 29 Sell…

Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by 07-12)…

AI/HPC power-buildout re-rate is the leg being bought the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board (MS…

AI-data-center re-rating leg is unwinding round-tripped from the $105.91 May ATH to the ~$84 50-day EMA under an unrebutted J Capital short thesis and a 2026-07-13 TD Cowen PT cut to $90; only the cyclical MCU/industrial recovery (~93% of…

Cheap cyclical furniture name squeezed ~24% off its 2026-06-24 post-earnings $17.29 close to $21.42, pressing the $23.18 52-week high but on a decelerating narrative: Q4 orders -6.3%, backlog -10.8%, a downgrade to Hold, CEO-transition…

Medicaid-margin-trough recovery, now fully re-rated: June's Illinois-win + BofA-double-upgrade breakout to ~$230 has matured into target catch-up (July raises to $230-250, but ratings stayed neutral and Barclays cut to $184). The whole leg…

Margin-led re-rate (Q1 FY27 GM 57.3%, +320bp; adj EPS $0.32 vs $0.08 est) is already priced at $38.65, ~3% off the $39.85 high after six weeks of chop. The live variable is the 2026-07-24 Section 122 expiry: the 10% Swiss-watch surcharge…

Post-COVID survivor re-rate has run its momentum leg and is now digesting a parabolic +31% push to a fresh 52-week high of $6.22 (June 26). Every driving catalyst is public, the move is idiosyncratic with no life-science-tools cluster…

Legacy plastics maker re-rated ~2.4x on a "Focused Transformation" MTS distribution arm in discontinued ops, capital concentrated behind Signature/MegaDeck composite matting (Infrastructure orders +130% YoY, Q1 adj EPS $0.44 vs $0.28).…

Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and Precise MRD colorectal/renal was pulled forward to Q3. Structure has repaired but now…

SolarWinds-spinoff MSP software vendor pivoting to cybersecurity via Adlumin MDR (26.7% of rev, +17.5% YoY); the cyber/MDR theme is accelerating but NABL's own tape is broken ~40% off, ~$4.77 near the $2.92 base low after a soft Q2 guide.…

Oncology-dx turnaround ACCELERATING NGS +26%, PTEN IHC CDx (first FDA IHC companion dx in prostate, paired to AZ's TRUQAP) launched Jul 9, and TD Cowen $14→$19 / BofA $11→$16 on Jul 13 lifted consensus to ~$15.67, back above spot. But Q2…

Cyclical zinc-recovery confirmed and fully priced: Q1 EBITDA +126% YoY and Aripuanã's record 13kt ramp drove a run to the $16.89 high, but the equity now chops $12–13 while LME zinc printed a fresh 2026 high near US$3,622 a bearish…

Newly-public consumer-measurement franchise (ex-NielsenIQ + GfK, Advent-backed) rebranding as an AI retail-media platform via a stream of partnership PRs (Unlimitail, Ogury, Lula; Jun–Jul 2026) with zero disclosed revenue impact. Narrative…

Post-capitulation base attempt, not an accelerating narrative: the 2026-06-30 print cleared a floored bar off the $41.35 low, but 2026-07-01 brought target cuts across eleven-plus desks with the average compressing to the low $50s the same…

AI-networking legacy re-rate extending on a harder catalyst leg first commercial AI-RAN platform with Nvidia (07-15) plus Taiwan Mobile, Orange Belgium and NestAI defense wins. Theme ACCELERATING, but the 2026-07-23 pre-open Q2 print is a…

Genuine VAR margin-mix turnaround (Q1 GM +240bps, cloud GP +35%) but a derivative AI tag: hardware GP guided flat, sales +1%. Range-bound $102–123 since the early-June rejection; ~$110 already sits above the ~$103 street target with a…

Overbought low-dollar turnaround bounce running straight into a binary ~7/31 earnings print. The only bullish flow, a 6/10 sweep of Jul-17 $5 calls, expires two weeks BEFORE the report a short-dated $5-reclaim bet, not an earnings…

Legacy steel-pipe maker re-rated into a water-infrastructure + precast roll-up on a record $373M WTS backlog, an ~83% Q1 beat, and the Permalok RBJ field win. Narrative intact but the setup is extended last near $148, ~35% above the ~$109…

PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul 29.…

Recovery leg re-fired: $66.06 (2026-06-05) → $71.49 on 2026-07-15 (+5.9%) → $73.20, back within 3% of the $75.25 high and ~6% ABOVE the $68.80 consensus target. Wells Fargo's 2026-07-10 note flags June financing data accelerating into a Q2…

Rig-reactivation cyclical is basing, not broken: June averaged 95 US rigs (vs ~90 Q2 guide), the July EIA STEO lifted 2026 Henry Hub to $3.67, gas rigs turned up 122→126, and Piper upgraded to Overweight 07-14. Price bottomed $8.57 (07-01)…

Post-print wreckage, not a turn. FY26 EPS held only via a ~$100M one-time tariff refund while the revenue guide went flat (2026-06-03, −25% overnight); BofA capitulated to Underperform/$70 on ~50% EMEA exposure (2026-06-25). The bounce to…

Luxury-resale turnaround has reached a real profitability inflection Q1 2026 (reported May 7) GMV +24%, revenue +19%, adjusted EBITDA tripled to $13.1M, FY guide raised. But the re-rate off the $4.91 low is largely spent: range-bound near…

The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10…

June's +20% deleveraging bounce has fully round-tripped: $1.99 (6/26) back to $1.73 (7/17), now under the 50-day near $1.79 after failing exactly at the $1.99 consensus PT. Balance sheet is fixed, narrative is not accelerating, and a…

Legacy-EMS AI re-rate (AMD/ZT Systems datacenter manufacturing) blew off to a $282.72 ATH then corrected ~16% off the highs; the est. ~2026-07-27 FQ3 print is now ~9 days out and is the binary it tests whether FQ2's +102% YoY surge was H2…

Online-styling turnaround printed a 5th straight quarter of growth and first sequential client gain (Q3, 2026-06-10), but the stock round-tripped the post-earnings pop back to ~$3.85 amid insider selling and a fresh Mizuho Underperform ($3…

Tariff-recovery leg has stalled into a $39.71–$47.11 range with insiders selling every rally and zero buys; the whole story now hinges on the confirmed 2026-07-30 Q2 print. Consensus targets sit at or below spot ($43.75, 07-16), adjusted…

Korea AI-infra narrative is loud while the ADR bleeds: $46.00 (06-02) to $30.62 (07-17), and both the 15GW plan (07-05) and JPMorgan's Overweight upgrade (~07-16) failed to hold a bid. The story flipped from AIDC margin accretion to ₩140T…

Legacy web-analytics SaaS (IPO $22, now ~$7) repositioning as an LLM-data supplier: a seven-digit AI training-data contract (disclosed 2026-05-18) plus AI Agents launch is the re-rating story. But Q1 2026 growth decelerated to +10% YoY and…

AR-pivot flagship the $2,195 SPECS glasses (2026-06-16) was rejected by the tape (−4%, design panned), and sell-side is now cutting targets DOWN through $5–6 (Wells $5, DA Davidson $5, Goldman $6, first week of July) into a hardening…

The split-momentum leg is dead. SNEX round-tripped from a $139.01 all-time-high close (2026-06-18) to $102.99 on 2026-07-17 down 12.5% in a week, 22.4% in a month while insiders dumped $94.2M over three months with zero buys.…

Busted-IPO turnaround leg re-accelerating: +30.5% in June on a Q1 profitability inflection plus live experience-economy catalysts FIFA World Cup resale, FestProtect launch, Einhorn's new stake, Guggenheim Buy initiation. At ~$12.82 it…

Coal-policy sympathy trade is fully dead: SXC has gone nowhere for three weeks, $8.39 on 2026-06-27 to $8.37 on 2026-07-17, pinned to the $8 shelf with no narrative velocity. The only live variable is the Q2 print, pulled forward to…

Fallen-angel telehealth turnaround re-rating off lows: TDOC doubled from its $4.40 low to a fresh $9.78 52-week high on the Walmart Better Care distribution deal and BetterHelp's shift to insurance-reimbursed visits. But total revenue…

The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates distribute shares in-kind to partners, losing the $17 secondary clearing shelf while Oppenheimer…

Beaten-down insulin-pump turnaround where the entire re-rate hinges on the tubeless Mobi 510(k) targeted for Q2 2026 submission, now overdue for confirmation plus gross margin scaling toward ~60% by Q4. But price is rolled over near the…

Debt refi (2026-07-09: $86M Deerfield convert → $75M OrbiMed term loan to 2031, no equity) removed the 2027 maturity wall and triggered a sell-side cluster Lake Street initiate $10 (7/06), BTIG $8→$9 (7/09), consensus $8.40. But a 24x…

Capex-heavy self-storage buildout bolted onto a moving business throttled by multi-decade-low housing turnover; lease-up drags margins while national storage street rates soften. No accelerating narrative and a rangebound tape dead money…

Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above…

Post-pivot autoimmune re-rating: Vor swapped failed cell therapy for China-approved dual BLyS/APRIL drug telitacicept (RemeGen deal, June 2025). Asset is de-risked and ~$19 sits far below the $45 average target but the global MG topline…

Q1 blowoff (+47% on 2026-06-02, adj EPS $0.60 vs $0.32) already re-rated the equity; shares ran to a $88.57 high then faded to the mid-$70s. Activist overhang cleared, sell-side neutralizing, no dated catalyst until the ~Aug-26 Q2 print. A…

Margin-inflection turnaround: Q1 (Apr 30) printed a 5-year-best adjusted EBITDA margin of 5.2% on +7.4% revenue, and Evercore's Jun 23 hike to $100 (+9.1% session) reignited the recovery. At ~$95 the stock is mid-range ~20% under its Jan…

Subprime lender re-rated to ~30x (from a historic 6–12x) on a buyback float-shrink plus credit-normalization "growth shift," +59% in six months into a fresh 52-week high of $227.68. Now overbought, directors selling, sell-side modeling…

Beaten-down dental franchise mid-turnaround: new CEO killed the dividend to cut debt and buy back stock, but Q1 revenue was dead flat and operating margin swung negative no accelerating narrative, a Hold-rated value trap into the…

Activist-anchored distressed-deleveraging special situation that fully round-tripped the June pop: $3.49 (2026-06-04) back to ~$2.80 (2026-07-02, -9.7% on the day), now at/below the $2.50 average target after Citi cut $3.50→$2.50.…

Delisting binary resolved to the survive side: EGM passed 2026-06-29, Psyga psilocybin reverse-merger closed 2026-06-30, delinquent 20-F filed, Nasdaq listing held. ADS popped ~+90% intraday to ~$2.70 (~$6.4M cap). Now an illiquid…

Tariff-margin-recovery turnaround stalled under the $51.89 multi-year high: China now <5% of 2026 COGS and FY guide raised, but a fresh Canaccord Hold/$45 target (2026-06-23) sits below spot and the whole trade is now a binary on the…

Legacy local-listings SaaS repositioning as the brand-knowledge layer for AI answer engines (Yext Scout), but organic ARR is flat-to-negative and shares halved into a June revenue miss. Buyback-supported value trap the…